NYSE
$328.95▲ 0.01%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $26.97BShares out 82.0M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
19- 4d agoPre-market26.10.21 19:518-KKey event#●●●
LABCORP HOLDINGS INC.Bullish
Labcorp Holdings Inc. has declared a cash dividend of $0.72 per share of its common stock. The dividend is payable on December 11, 2026, to stockholders of record as of the close of business on November 24, 2026.…more
$328.95+0.01%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 9.30Pre-market26.09.30 21:328-KKey event
LABCORP HOLDINGS INC.
Labcorp Holdings Inc. has scheduled the release of its financial results for the third quarter of 2026. The results will be announced before the market opens on Wednesday, October 28, 2026, followed by a webcast discussion at 9:00 a.m. ET that day.…more
$328.95+0.01%vs prev closeView filingShare - 9.22After-hours26.09.23 05:438-KKey event
LABCORP HOLDINGS INC.
Labcorp Holdings Inc. reaffirmed its 2026-2029 long-term financial outlook despite concerns regarding the preliminary 2027-2029 clinical laboratory fee schedule released by CMS. The company maintains targets of 5-8% annual revenue growth, 75-150 basis points of adjusted operating margin expansion, and 8.5-11.5% annual adjusted EPS growth, with further impact assessments expected in February 2027.…more
$328.95+0.01%vs prev closeView filingShare
18 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 2d agoPre-market26.10.23 21:06#●●●#●●●
Labcorp Expands Cervical Cancer Screening with BD Onclarity HPV Assay
Labcorp will become the first commercial laboratory to offer the FDA-approved BD Onclarity HPV assay across various clinical and at-home settings. This initiative leverages Labcorp's extensive network to improve nationwide access to comprehensive cervical cancer screening.…more
$328.95+0.01%vs prev closeDetected5m · 30m · 60m · Next dayPLUSShareBenzinga
- 2d agoAfter-hours26.10.23 05:36
●●●●●●●● ●●●●● ●●●●●●
Charles River Laboratories has entered a research collaboration with the FDA and Labcorp to develop standardized tools for quantifying the abuse potential of new drugs. This initiative focuses on enhancing regulatory science and safety evaluation rather than immediate commercial revenue.…more
$328.95+0.01%vs prev closeShareBenzinga - 4d agoRegular26.10.21 01:37
●●●●●●●● ●●●●● ●●●●●●
Myriad Genetics has agreed to sell its struggling prenatal health testing business to Labcorp for $210 million in an all-cash deal. The divestiture allows Myriad to offload a declining segment while Labcorp aims to integrate these assets to drive future diagnostic revenue.…more
$328.95+0.01%vs prev closeShareBenzinga
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report